Sr. Manager, Commercial Strategic Sourcing

Mineralys Therapeutics is a clinical-stage biopharmaceutical company headquartered in Radnor, Pennsylvania, specializing in developing treatments for diseases driven by dysregulated aldosterone. Their lead product candidate, lorundrostat, is an orally administered, highly selective aldosterone synthase inhibitor aimed at addressing hypertension and related comorbidities such as chronic kidney disease and obstructive sleep apnea. The company operates with a fully remote workforce, fostering a flexible and collaborative environment.